Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2, Cystic Fibrosis Trial in Atlanta (Oral Glucose Tolerance Test, High Glycemic Index Meal, Low Glycemic Index

Completed
  • Diabetes Mellitus, Type 2
  • Cystic Fibrosis
  • Oral Glucose Tolerance Test
  • +4 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta and Emory University
Jun 1, 2020

Diabetes, Type 2, Non-Alcoholic Fatty Liver Disease Trial in Canada, United States (BFKB8488A, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Non-Alcoholic Fatty Liver Disease
  • Anniston, Alabama
  • +17 more
Mar 25, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Diabetes, Type 2 Trial in Atlanta (SLEEP-Extend intervention, Control)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • SLEEP-Extend intervention
  • Control
  • Atlanta, Georgia
  • +1 more
Dec 12, 2019

Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Diabetic Nephropathy
  • Birmingham, Alabama
  • +592 more
Dec 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +208 more
Oct 2, 2019

Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Human Insulin Inhalation Powder
  • Insulin Glargine
  • Fresno, California
  • +68 more
Sep 6, 2019

Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300 U/ml
  • +3 more
  • Birmingham, Alabama
  • +426 more
Aug 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +149 more
Jul 30, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +96 more
Mar 6, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +2 more
  • Glendale, Arizona
  • +143 more
Jan 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Worldwide (Bolus Insulin Patch (Calibra Finesse), Insulin Pen (Novo-Nordisk FlexPen®))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Bolus Insulin Patch (Calibra Finesse)
  • Insulin Pen (Novo-Nordisk FlexPen®)
  • Phoenix, Arizona
  • +51 more
Nov 6, 2018

Diabetes, Type 2 Trial in Atlanta (Intralipid 20%, Glucose infusion)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Intralipid 20%
  • Glucose infusion
  • Atlanta, Georgia
    Grady Memorial Hospital
Sep 14, 2018

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin glargine, Inhaled Insulin (Exubera))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • Inhaled Insulin (Exubera)
  • Phoenix, Arizona
  • +72 more
Aug 31, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Insulin NPH, Diet/exercise)

Terminated
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin detemir
  • +2 more
  • Tucson, Arizona
  • +81 more
Aug 9, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018